142 related articles for article (PubMed ID: 37165798)
1. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship.
Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W
Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
Xu Z; Pan B; Chen L; Xu D
Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
[TBL] [Abstract][Full Text] [Related]
4. The anti-breast cancer potential of dihydroartemisinin-isatin hybrids with hydrogen bond donors at C-3 position of isatin moiety.
Ding F; Chen X; Cao W; Dong T; Wang P
Fitoterapia; 2023 Mar; 165():105426. PubMed ID: 36608710
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-breast cancer properties of butyric ester tethered dihydroartemisinin-isatin hybrids.
Zhao S; Zhang X; Tang M; Liu X; Deng J; Zhou W; Xu Z
Med Chem Res; 2023; 32(4):705-712. PubMed ID: 36816432
[TBL] [Abstract][Full Text] [Related]
6. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
7. The Anti-Breast Cancer Activity of Dihydroartemisinin-5-methylisatin Hybrids Tethered via Different Carbon Spacers.
Yao Y; Wang H; Xu J; Gao F; Cao W
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432095
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
9. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activity.
Wang R; Zhang Q; Chen M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200563. PubMed ID: 36572639
[TBL] [Abstract][Full Text] [Related]
11. Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and
Wang R; Huang R; Yuan Y; Wang Z; Shen K
Front Mol Biosci; 2023; 10():1293763. PubMed ID: 37928644
[TBL] [Abstract][Full Text] [Related]
12. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents.
Singh A; Kaur H; Arora S; Bedi PMS
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100368. PubMed ID: 34783073
[TBL] [Abstract][Full Text] [Related]
14. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
[TBL] [Abstract][Full Text] [Related]
15. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
16. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin.
Luan S; Zhong H; Zhao X; Yang J; Jing Y; Liu D; Zhao L
Eur J Med Chem; 2017 Dec; 141():584-595. PubMed ID: 29102180
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Antiproliferative Activity of Novel Dehydroabietic Acid-Chalcone Hybrids.
Grigoropoulou S; Manou D; Antoniou AI; Tsirogianni A; Siciliano C; Theocharis AD; Athanassopoulos CM
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684559
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]